Publicaciones en colaboración con investigadores/as de Imperial College London (99)

2023

  1. Anonymous Comparison of Various Angiography-Derived Fractional Flow Reserve Software With Pressure-Derived Physiological Assessment

    JACC: Cardiovascular Interventions, Vol. 16, Núm. 14, pp. 1778-1790

  2. Coronary Physiology as Part of a State-of-the-Art Percutaneous Coronary Intervention Strategy: Lessons from SYNTAX II and Beyond

    Interventional Cardiology Clinics, Vol. 12, Núm. 1, pp. 141-153

  3. Coronary microcirculation in nonculprit vessel territory in reperfused acute myocardial infarction

    Microvascular Research, Vol. 147

  4. Deferred Versus Performed Revascularization for Left Main Coronary Disease with Hemodynamic Significance

    Circulation: Cardiovascular Interventions, Vol. 16, Núm. 6, pp. E012700

  5. Development of artificial intelligence tools for invasive Doppler-based coronary microvascular assessment

    European Heart Journal - Digital Health, Vol. 4, Núm. 4, pp. 291-301

  6. Evolving Management Paradigm for Stable Ischemic Heart Disease Patients: JACC Review Topic of the Week

    Journal of the American College of Cardiology, Vol. 81, Núm. 5, pp. 505-514

  7. Impact of Age at the Time of the First ST-Elevation Myocardial Infarction on 10-Year Outcomes (from the EXAMINATION-EXTEND Trial)

    American Journal of Cardiology, Vol. 190, pp. 32-40

  8. Impact of stenosis resistance and coronary flow capacity on fractional flow reserve and instantaneous wave-free ratio discordance: a combined analysis of DEFINE-FLOW and IDEAL

    Netherlands Heart Journal, Vol. 31, Núm. 11, pp. 434-443

  9. Physiology-guided PCI versus CABG for left main coronary artery disease: insights from the DEFINE-LM registry

    Cardiovascular Intervention and Therapeutics, Vol. 38, Núm. 3, pp. 287-298

2022

  1. Angiography derived assessment of the coronary microcirculation: is it ready for prime time?

    Expert Review of Cardiovascular Therapy, Vol. 20, Núm. 7, pp. 549-566

  2. Angiography-derived physiology guidance vs usual care in an All-comers PCI population treated with the healing-targeted supreme stent and Ticagrelor monotherapy: PIONEER IV trial design

    American Heart Journal, Vol. 246, pp. 32-43

  3. Five-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with de novo three-vessel disease: Final results of the SYNTAX II study

    European Heart Journal, Vol. 43, Núm. 13, pp. 1307-1316

  4. Gradual Versus Abrupt Reperfusion During Primary Percutaneous Coronary Interventions in ST-Segment-Elevation Myocardial Infarction (GUARD)

    Journal of the American Heart Association, Vol. 11, Núm. 10, pp. e024172

  5. Impact of Diabetes on 10-Year Outcomes Following ST-Segment–Elevation Myocardial Infarction: Insights From the EXAMINATION-EXTEND Trial

    Journal of the American Heart Association, Vol. 11, Núm. 23

  6. Phasic flow patterns of right versus left coronary arteries in patients undergoing clinical physiological assessment

    EuroIntervention, Vol. 17, Núm. 15, pp. 1260-1270

  7. Prevalence and Disease Spectrum of Extracoronary Arterial Abnormalities in Spontaneous Coronary Artery Dissection

    JAMA Cardiology, Vol. 7, Núm. 2, pp. 159-166

  8. Sex Differences in 10-Year Outcomes Following STEMI: A Subanalysis From the EXAMINATION-EXTEND Trial

    JACC: Cardiovascular Interventions, Vol. 15, Núm. 19, pp. 1965-1973